WT
OXFD

Wellcome Trust’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Wellcome Trust’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,350
Closed -$73K – 34
2014
Q2 		$73K Buy
+4,350
New +$78.3K ﹤0.01% 31

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellcome Trust's OXFD Position: Q3 2014 in Review

Wellcome Trust sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2014, closing a stake of 4,350 shares — an estimated $73K sold.

Wellcome Trust first reported a position in OXFD in Q2 2014 and held it in 1 quarter. The position peaked at $73K in Q2 2014. 49 funds tracked by Wall St. Rank hold OXFD as of Q3 2014.

  • Wellcome Trust reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2014 after selling out during the quarter.
  • Wellcome Trust sold 4,350 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2014, an estimated $73K.
  • Wellcome Trust first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2014 and held it in 1 quarter.
  • Wellcome Trust's Oxford Immunotec Global PLC Ordinary Shares position peaked at $73K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2014.

Based on Wellcome Trust's 13F filing for Q3 2014, filed 17 Oct 2014.